Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A C D E F G I J K L M N O P R S T U V X Z

Tyzeka®/Sebivo™

telbivudine
Infectious disease
Established Medicines
Global Product Site USA Germany United Kingdom Poland Canada Turkey

Tyverb®

lapatinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Trileptal®

oxcarbazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Travatan® BAK-Free

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan Z®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Tobradex®

tobramycin, dexamethasone
Ophthalmology
Ophthalmology
USA Germany Austria Poland Netherlands Canada

TOBI® Podhaler™

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI®

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tegretol®

carbamazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tasigna®

nilotinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tafinlar®

dabrafenib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan